Objective:To study the effects of cells ’ and bacteria ’s adhesion and proliferation on different fiber diameters of polypyrrole coating with electricity.Methods:Titanium coated with polypyr-role was divided into no electrical stimulation and stimulation groups,each group had 30-60 nm,70-1 00 nm,1 30-1 70 nm diameters of the fiber.MC3 T3 cells and Staphylococcus aureus (S.aureus)were inoculated on different fiber diameters of polypyrrole coating with and without electric stimulation .We gave the electrical stimulation group 1 00 mV for 1 h and every 24 hours gave it 1 h stimulation,and no e-lectrical stimulation group was not managed.We used scanning electron microscope (SEM)to observe the cells’and bacteria’s morphology.The cells were given 20 mL CCK-8 solutions after 1 ,3,7 days’ cultivation,then incubated for 2 h,the solution was transferred to 96-well plate,we measured the cells’ CCK-8 of the 30-60 nm,70-1 00 nm,and 1 30-1 70 nm groups by Elisa.The cells on different fiber diameters were also stained by live-dead cell staining kit,TritonX-1 00 and DAPI.We used PBS to wash and glycerin to seal them.The live-dead situation and morphology were tested by co focal microscope. The bacterial were stained by Live/dead baclight bacterial viability kits,we detect the suspension’s D of the 30-60 nm,70-1 00 nm,and 1 30-1 70 nm groups,and also observed the bacteria’s survival situa-tion by co focal microscope.Results:The CCK-8 of the cells with direct current stimulation was higher than that of the unpowered group (F=1 2.248,P=0.006).The smaller the fiber diameter,the better was the cell’s adhesion and proliferation (F=9.261 ,P=0.005).The bacterial suspension’s D of the electric group was lower than that of the unpowered group,and the fiber diameter had no significant effect on the bacteria’s growth(F=9.641 ,P=0.036).Conclusion:Polypyrrole coating with electricity can promote the cell’s proliferation and inhibit the bacteria’s proliferation,and the cell growth on small fiber diameter coating is better.There is no difference in the bacterial growth of different fiber diameter coatings.

10.3969/j.issn.1000-3606.2013.06.019

OBJECTIVE: To explore the genetic basis for a child featuring global developmental disorder with epilepsy. METHODS: A child who had presented at Guangzhou Women and Children's Medical Center in July 2022 was selected as the study subject. Clinical data was collected. Potential variant was detected by whole exome sequencing (WES). Candidate variant was validated by Sanger sequencing and bioinformatic analysis. RESULTS: The child, a three-year-old ethnic Zhuang Chinese girl, had presented with global developmental disorder and epilepsy, for which rehabilitation therapy was ineffective. Genetic testing revealed that she has harbored a homozygous c.821T>C (p.Leu274Pro) missense variant of the PIGW gene, for which both of her parents and sister were heterozygous carriers. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was classified as variant of uncertain significance. CONCLUSION The homozygous c.821T>C (p.Leu274Pro) variant of the PIGW gene probably underlay the onset of disease in this child. Above finding has enriched the mutational spectrum of the PIGW gene.
Child, Preschool ; Female ; Humans ; Computational Biology ; Developmental Disabilities ; Epilepsy/genetics* ; Genetic Testing ; Homozygote

[Abstract] Objective: To investigate the expression of chemokine-like factor-like MARVEL transmembrane domain-containing family member 6 (CMTM6) in breast cancer tissues and its correlation with clinicopathological features and prognosis of patients. Methods:Atotal of 136 breast cancer tissue chips (purchased from Superchip Company), including 42 pairs of matched cancer and paracancerous tissues, were used for this study. The expression level of CMTM6 in cancer and paracancerous tissues was detected by immunohistochemistry. The comparison of CMTM6 expression between breast cancer and paracancerous tissues was conducted by paired χ2 test. The relationship between CMTM6 expression in breast cancer tissues and the clinicopathological characteristics of patients was analyzed by χ2 test. Kaplan-Meier and Log rank test analyses were used to analyze the relationship between CMTM6 expression and the survival of patients, and Cox model was used to evaluate the effect of different indicators on the prognosis of patients. Results: The expression of CMTM6 in breast cancer tissues was significantly higher than that in paracancerous tissues (P<0.01). The expression of CMTM6 was correlated with pathological type of breast cancer and HER2 positivity (P<0.05). The survival time of patients in CMTM6 high expression group was significantly shorter than that of patients in CMTM6 low expression group (P<0.05). Pathological type (HR=10.374, 95%CI: 3.529-30.497, P<0.01), TNM stage (HR=4.599, 95%CI: 1.784-11.856, P<0.01), triple-negative breast cancer (HR=3.370, 95%CI: 1.055-10.761, P<0.05) and high expression of CMTM6 (HR=0.195, 95%CI: 0.073-0.518, P<0.01) were independent risk factors for prognosis of breast cancer patients. Conclusion: CMTM6 is highly expressed in breast cancer tissues, which can be used as a risk factor for prognosis evaluation of breast cancer patients.